<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T18:20:56Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/164059" metadataPrefix="mets">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/164059</identifier><datestamp>2025-11-20T14:36:14Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478913</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478924</setSpec></header><metadata><mets xmlns="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" ID="&#xa;&#x9;&#x9;&#x9;&#x9;DSpace_ITEM_2445-164059" TYPE="DSpace ITEM" PROFILE="DSpace METS SIP Profile 1.0" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd" OBJID="&#xa;&#x9;&#x9;&#x9;&#x9;hdl:2445/164059">
   <metsHdr CREATEDATE="2026-04-13T20:20:56Z">
      <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
         <name>RECERCAT</name>
      </agent>
   </metsHdr>
   <dmdSec ID="DMD_2445_164059">
      <mdWrap MDTYPE="MODS">
         <xmlData xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
            <mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Khymenets, Olha</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Crespo, M. Carmen</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Dangles, Olivier</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Rakotomanomana, N.</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Andrés Lacueva, Ma. Cristina</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Visioli, F. (Francesco)</mods:namePart>
               </mods:name>
               <mods:originInfo>
                  <mods:dateIssued encoding="iso8601">2020-06-03T07:11:22Z2020-06-03T07:11:22Z2016-03-312020-06-03T07:11:22Z</mods:dateIssued>
               </mods:originInfo>
               <mods:identifier type="none"/>
               <mods:abstract>Among the various (poly)phenols that are being sold as such or as part of a more complex mixture, hydroxytyrosol (HT) is the only one that bears a European Food Safety Authority health claim. Therefore, several HT-based products are being developed and sold and it becomes necessary to evaluate its accessibility following ingestion. Twenty-one volunteers were recruited for a randomized, crossover, placebo-controlled, and double-blind intervention study.We performed a Latin square design: after one-week washout, i.e. olive-free diet, subjects were randomly assigned to the placebo (maltodextrin), 5, or 25 mg/day HT group. Twenty-four hour urine samples were collected after the intervention week, and baseline urines were collected the week before the study and during periods of washout. The results show that HT given as the foremost component of a nutraceutical preparation is bioavailable and is recovered in the urine chiefly as sulphate-3′.</mods:abstract>
               <mods:language>
                  <mods:languageTerm authority="rfc3066"/>
               </mods:language>
               <mods:accessCondition type="useAndReproduction">cc-by-nc-nd (c) Khymenets, Olha et al., 2016 http://creativecommons.org/licenses/by-nc-nd/3.0/es info:eu-repo/semantics/openAccess</mods:accessCondition>
               <mods:subject>
                  <mods:topic>Salut</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Suplements nutritius</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Espectrometria de masses</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Biodisponibilitat</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Assaigs clínics</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Metabòlits</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Polifenols</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Orina</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Health</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Dietary supplements</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Mass spectrometry</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Bioavailability</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Clinical trials</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Metabolites</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Polyphenols</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Urine</mods:topic>
               </mods:subject>
               <mods:titleInfo>
                  <mods:title>Human hydroxytyrosol's absorption and excretion from a nutraceutical</mods:title>
               </mods:titleInfo>
               <mods:genre>info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion</mods:genre>
            </mods:mods>
         </xmlData>
      </mdWrap>
   </dmdSec>
   <structMap LABEL="DSpace Object" TYPE="LOGICAL">
      <div TYPE="DSpace Object Contents" ADMID="DMD_2445_164059"/>
   </structMap>
</mets></metadata></record></GetRecord></OAI-PMH>